VG-1000™ is a powerful immune system modulator for the biological
prevention and treatment of cancer. It is a non-toxic, organic
product which acts much like a vaccine to unmask cancerous cells as
they mutate into malignancies, and enhances the person’s immune
system ability to control or eliminate the cancer.
Comprehensive Cancer Care: Integrating
Complementary & Alternative Therapies. Trophoblastic Hormones and
Cancer: A Breakthrough in Treatment?
Unlike most therapies that are cytotoxic, VG-1000™ therapy is
designed to weaken or suppress factors within the tumor that "turn
off" the normal immune defenses of the patient, and enable the
patient’s immune system to respond against the cancer.
The Russian physician, Dr. Valentin I. Govallo, MD, Ph.D.,
originally developed this revolutionary immunologic theory through
studies of the parallels between the mother-fetus and host-tumor
immune interaction systems.
VG-1000 is a
vaccine-like biological response modifier acting against cancer; it
is based on specific cells extracted from human placenta.
This unique
product has a history that starts at the beginning of the last
century. In 1901 the Scottish embryologist, John Beard,
rigorously trained in Germany, became a lecturer in embryology at
the University of Edinburgh, one of the world’s great medical
schools. He was the first to notice that the cancer cells bear a
marked resemblance to the cells that normally surrounds the healthy,
developing embryo, called the trophoblast cells.
It is the
trophoblast that attach themselves onto and aggressively eat a hole
in the uterus.
These cells
burrow deeply and implant the embryo beneath the womb’s surface and
becomes the chorionic villi as the fetus’ half of the placenta.
The
trophoblast’s behavior is anarchistic, aggressive and relentless. It
is primitive, corrosive, invasive and “wild”.
What other type
of cell is known to behave in such an aggressive, invasive manner
despite all the effort at rejection made by the immune system?
The answer
is, of course, the CANCER cell.
This astounding
concept gives John Beard a brilliant flash of inspiration while
literally seated at the microscope. He, familiar with the behavior
of the trophoblast in pregnancy studies, observed the behavior of
malignant, live cancer cells under microscopic examination. He
summed it up in these words: “These ( malignant cells) behave
just like trophoblast!”
Beard published
his conclusions in “The Lancet” for February 1905, and his treatment
of cancers in the same publication in 1906 and 1907, where they can
be found to this day.
Cancer, said
Beard, is simply trophoblast in the wrong place at the wrong time,
triggered into malignant life by what we would call hormones and
carcinogens.
Then, in the
middle of the Beard furor, World War I broke out, and later the rise
of new “magical“ radiation therapy and crude chemotherapy directed
medical interest away from
Beard’s thesis
and embryonic cell/ placenta therapy for the treatment of cancer.
Except in some academic circles, his ideas concerning the origin of
cancer have languished in the dusty stack rooms of medical history,
spurned by modern oncology in favor of newer theories.
But
increasingly it is becoming apparent that long before molecular
biology was born, Beard may have hit upon a core truth :
STEM CELLS
may ultimately lie at the root of many kinds of cancer!
While Beard
himself would not have been aware of the existence of stem cells,
his theory concerning the origins of cancer is remarkably compatible
with the concept of stem cells as the source of malignancy .
Researchers have found that malignant stem cells causes
acute and
chronic myelogenous leukemia, and were able to identify cancer
stem cells in blood cancers as well as in brain and breast tumors.
In certain stomach cancers the cells that initiate the malignancy
originate not in the tissue of the stomach itself, but are actually
stem cells that have migrated there from the bone marrow .(Sent to
the stomach in a response to an infection (Helicobacter pilori)
as part of the body’s attempt to heal
itself.)
From the University of Michigan :
“In contrary to
what is generally assumed, not all tumor cells are equally capable
of causing metastatic cancer. In fact in experimental breast tumors
only a tiny fraction -less than one percent- of tumor cells
are actually capable of metastasis. These highly malignant cells are
identifiable as stem cells”
A Russian
scientist Dr. Valentin I Govallo, disappointed by the
failures of his cancer research and treatment, theorized that the
immune system itself was hindering the activity of the immune
system, emitting certain “blocking factors”. Since some of these
blocking factors seem to bear a striking resemblance to those
emitted by an embryo during pregnancy, Govallo had the brilliant
idea of using placental extracts to immunize the patient against the
fetus like behavior of the cancer cells. He found that an extract of
human chorionic villi, effectively blocks all reactions of cell
immunity, when added to a test tube of white blood cells.
And in cancer
patients he found a quantitative reduction of the tumor mass, after
immunization with placental extract, and decreased production of
blocking factors, just as a decrease in the production of blocking
factors reduces tumor mass.
Even if VG-1000
is not literally a vaccine, in such a situation, the injected tissue
extract can be viewed as a conditional equivalent of an anti-cancer
vaccine.
Govallo said
that it is not yet exactly clear how the placental extract effect
works, the statistics in his book show a 77.1% 5 year survival
rate. He published his results in
The
Immunology of Pregnancy and Cancer, Nova Science Publishers,
Commack, New York, ISBN 1-56072-096-4.
His first
“prototype” placental anticancer extracts were crude, natural
compounds which had to be shipped in dry ice.
Dr. Valentin I.
Govallo passed away in 2004 and his personal website is banned and
don’t exist anymore.
However, if you
want to take a look in his questions and answers and case
histories, click on the navigate bar on the left side.
Since 1999,
however, there is a third generation extract, VG-1000, which has all
the advantages of a modern product: it is lyophilized, standardized
and manufactured under strict quality control rules. Due to its
amino acid content, it is accepted as a food supplement in a (drink)
ampoule.
